| Patents for C07D 309 - Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings (12,815) |
|---|
| 04/03/2003 | US20030064935 Amino acid complexes of C-aryl glucosides for treatment of diabetes and method |
| 04/02/2003 | EP1298115A1 Process for the preparation of polyhydric alcohols |
| 04/02/2003 | EP1296716A2 New formulation |
| 04/02/2003 | EP0807617B1 Process for preparing 1,5-pentanediol derivative |
| 04/02/2003 | CN1407990A C-aryl glucoside sgltz inhibitors |
| 04/02/2003 | CN1406938A Lactonization in course of preparing lovastatin or similarities |
| 04/01/2003 | US6541655 Catalytic compositions and methods for asymmetric allylic alkylation |
| 04/01/2003 | US6541511 Treatment and prophylaxis of hypercholesterolemia and of various cardiac disorders. |
| 04/01/2003 | US6541489 Excellent inhibitory activity of one or more matrix metalloprotease (MMP) enzymes, such as MMP-2, MMP-9, and MMP-13, while exhibiting substantially less inhibition at least of MMP- 1 |
| 03/27/2003 | WO2003024975A1 Laulimalide-derivatives, their use and process for the production of laulimalide and laulimalide-derivatives |
| 03/27/2003 | WO2003024949A1 Dna-pk inhibitors |
| 03/27/2003 | WO2003024529A1 Simplified sarcodictyn derivatives as anti-tumor agents |
| 03/27/2003 | WO2002098854A3 Process for preparing chiral diol sulfones and dihydroxy acid hmg coa reductase inhibitors |
| 03/27/2003 | WO2002060859A3 Cyclic derivatives as modulators of chemokine receptor activity |
| 03/27/2003 | US20030060633 Asymmetric synthesis of kavalactones |
| 03/27/2003 | CA2460244A1 Simplified sarcodictyn derivatives as anti-tumor agents |
| 03/27/2003 | CA2454023A1 Dna-pk inhibitors in the treatment of retroviral mediated diseases |
| 03/26/2003 | EP1295886A1 Laulimalide-derivates, their use and process for the production of laulimalide and laulimalide-derivates |
| 03/26/2003 | EP1294706A1 A process for lactonization to produce simvastatin |
| 03/26/2003 | EP0882113B1 Process for preparing compositions useful as intermediates for preparing lubricating oil and fuel additives and derivatives thereof |
| 03/26/2003 | CN1406283A Method of purifying a fermentation broth |
| 03/25/2003 | US6537527 Skin lightening compositions |
| 03/20/2003 | WO2003022841A1 Intermediates for preparing neuraminidase inhibitor conjugates |
| 03/20/2003 | WO2003022787A1 Method for preparing unsaturated fatty hydroxy-acids and esters thereof, their use in pharmaceutical and/or cosmetic compositions |
| 03/20/2003 | US20030055246 Serine protease inhibitors |
| 03/20/2003 | US20030055035 Useful in hyperpolarizing cell membranes, opening potassium channels, relaxing smooth muscle cells, and inhibiting bladder contractions |
| 03/20/2003 | CA2459760A1 Method for preparing unsaturated fatty hydroxy-acids and esters thereof, their use in pharmaceutical and/or cosmetic compositions |
| 03/19/2003 | EP1292555A2 Catalytic hydrogenation of ketones and aldehydes |
| 03/19/2003 | EP0799228B1 3-aryl-tetronic acid derivatives, the production thereof and the use thereof as anti-parasitic agents |
| 03/18/2003 | CA2238377C Cyclohexenone oxime ether metal salts |
| 03/13/2003 | WO2003020684A1 (alpha)-haloenamine reagents |
| 03/13/2003 | WO2002078625A3 Therapeutic combinations for cardiovascular and inflammatory indications |
| 03/13/2003 | WO2002024194A3 Use of statins (hmg-coa reductase inhibitors) for the preparation of medicament as a novel type of immunomodulator, immunosuppressor and anti-inflammatory agent |
| 03/13/2003 | US20030050482 Process of lactonization in the preparation of statins |
| 03/13/2003 | CA2458859A1 (alpha)-haloenamine reagents |
| 03/12/2003 | EP1289972A1 Serine protease inhibitors |
| 03/11/2003 | US6531299 Incubating proteins comprising polyketide synthase, butyryl Coenzyme A, and thioester of butyric acid |
| 03/06/2003 | WO2003018570A1 Process of lactonization in the preparation of statins |
| 03/06/2003 | WO2003018553A1 Oral antidiabetic agents |
| 03/06/2003 | WO2003018552A2 Aromatic and heteroaromatic acid halides for synthesizing polyamides |
| 03/06/2003 | WO2003018535A2 Novel aminobenzoephenones |
| 03/06/2003 | WO2002083066A3 Amino acid complexes of c-aryl glucosides for treatment of diabetes and method |
| 03/06/2003 | US20030044644 4-dicyanomethylene-2-p-dimethylaminostyryl-6-methyl-4H-pyran derivatives with modified electron withdrawing groups and electron donating groups |
| 03/06/2003 | CA2458621A1 Oral antidiabetic agents |
| 03/06/2003 | CA2458616A1 Aromatic and heteroaromatic acid halides for synthesizing polyamides |
| 03/05/2003 | EP1288212A1 Process of lactonization in the preparation of statins |
| 03/05/2003 | EP1286967A1 Cyclohexane derivatives and their use as therapeutic agents |
| 03/05/2003 | EP1286956A1 Phenyl-substituted 2-enamino-keto nitriles |
| 03/05/2003 | EP0627433B1 Process for producing imidazopyridine derivative and intermediate |
| 03/05/2003 | CN1102588C Process for manufacturing simwastatin from lovastatin or mevinolinic acid |
| 03/04/2003 | US6528510 HIV protease inhibitors |
| 02/27/2003 | WO2003016317A1 Processes for preparing calcium salt forms of statins |
| 02/27/2003 | WO2002092588A3 Aromatic sulfone hydroxamates and their use as protease inhibitors |
| 02/27/2003 | WO2002053517A3 Process for stereoselective synthesis of prostacyclin derivatives |
| 02/27/2003 | WO2002017911A1 Parathyroid hormone production inhibitors containing vitamin d3 derivatives |
| 02/27/2003 | US20030040084 Macrolide analogs |
| 02/27/2003 | CA2420759A1 Parathyroid hormone production inhibitors containing vitamin d3 derivatives |
| 02/25/2003 | US6525206 Compounds with high monoamine transporter affinity |
| 02/25/2003 | US6525205 Lactonization process |
| 02/25/2003 | US6525052 Compounds useful as reversible inhibitors of cysteine proteases |
| 02/20/2003 | WO2003014102A1 Certain substituted polyketides, pharmaceutical compositions containing them and their use in treating tumors |
| 02/20/2003 | WO2003013542A1 Asymmetric synthesis of kavalactones |
| 02/20/2003 | WO2003013502A1 Compounds which mimic the chemical and biological properties of discodermolide |
| 02/20/2003 | WO2002032842A9 Compounds with high monoamine transporter affinity |
| 02/20/2003 | WO2002030882A9 Sulfoxide and bis-sulfoxide compounds and compositions for cholesterol management and related uses |
| 02/20/2003 | WO2002030860A9 Ketone compounds and compositions for cholesterol management and related uses |
| 02/20/2003 | CA2456720A1 Asymmetric synthesis of kavalactones |
| 02/20/2003 | CA2456553A1 Compounds which mimic the chemical and biological properties of discodermolide |
| 02/20/2003 | CA2454081A1 Certain substituted polyketides, pharmaceutical compositions containing them and their use in treating tumors |
| 02/19/2003 | EP1284264A1 Process for producing simvastatin |
| 02/19/2003 | EP1144360A4 A method for the synthesis of compounds of formula 1 and derivatives thereof |
| 02/19/2003 | CN1398189A Combination therapy of radiation and COX-2 inhibitor for treatment of neoplasia |
| 02/19/2003 | CN1101809C Processes for preparing 3-arylsulfur hydroxamic acids |
| 02/19/2003 | CN1101805C key intermediates in mfg. of simvastatin |
| 02/18/2003 | US6521762 Process for purifying lovastatin and simvastatin with reduced levels of dimeric impurities |
| 02/18/2003 | US6521650 Amines as pharmaceutical agents |
| 02/13/2003 | WO2002040462A3 Cysteine protease inhibitors |
| 02/12/2003 | EP1282415A2 Compounds and methods for regulating bacterial growth and pathogenesis |
| 02/12/2003 | EP0871623B1 3-azetidinylalkylpiperidines or -pyrrolidines as tachykinin antagonists |
| 02/12/2003 | CN1396919A Synthesis of 3,6-dialkyl-5,6-dihydro-4-hydroxy-pyran-2-one |
| 02/12/2003 | CN1396807A 除草组合物 Herbicidal compositions |
| 02/12/2003 | CN1396262A Preparation method of epoxyinalool or mixture containing epoxy inalool |
| 02/11/2003 | US6518460 Processes for preparing 3-arylsulfur hydroxamic acids |
| 02/11/2003 | US6518326 Open chain alkoxyamine compounds and their use as polymerization regulators |
| 02/11/2003 | US6518303 Selectively inhibit COX-2 in preference to COX-1 and are useful in the treatment of COX-2 mediated diseases, such as inflammation, pain, fever and asthma with fewer side effects |
| 02/11/2003 | US6518289 1-substituted-1-aminomethyl-cycloalkane derivatives (=gabapentin analogues), their preparation and their use in the treatment of neurological disorders |
| 02/10/2003 | WO2002014250A1 Derivatives of 4-(trifluoromethyl)-phenol and 4-(trifluoromethylphenyl)-2-(tetrahydropyranyl) ether and method for producing the same |
| 02/10/2003 | CA2418749A1 Derivatives of 4-(trifluoromethyl)-phenol and 4-(trifluoromethylphenyl)-2-(tetrahydropyranyl) ether and method for producing the same |
| 02/06/2003 | WO2003010130A1 Amino acid derivatives |
| 02/05/2003 | EP1280770A1 C 2? phenyl-substituted cyclic keto-enols used as pesticides and herbicides |
| 02/05/2003 | EP0745087B1 Novel cytotoxic macrolides, their isolation from a marine sponge and their use as antitumor agents |
| 02/05/2003 | CN1394855A Substituted heterocyclic compound |
| 02/04/2003 | US6515117 C-aryl glucoside SGLT2 inhibitors and method |
| 02/03/2003 | WO2002016312A2 Novel compounds inhibiting factor xa activity |
| 02/03/2003 | CA2418283A1 Novel compounds inhibiting factor xa activity |
| 01/30/2003 | WO2003007954A2 Sulfonyl aryl hydroxamates and their use as matrix metalloprotease inhibitors |
| 01/30/2003 | WO2003007878A2 Antifungal agents of sordarin derivatives |
| 01/30/2003 | US20030022865 Sulfoxide and bis-sulfoxide compounds and compositions for cholesterol management and related uses |
| 01/30/2003 | CA2453613A1 Sulfonyl aryl hydroxamates and their use as matrix metalloprotease inhibitors |
| 01/29/2003 | EP1278747A1 Pyrano, piperidino, and thiopyrano compounds and methods of use |